Compare MQ & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MQ | ATRC |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2021 | 2005 |
| Metric | MQ | ATRC |
|---|---|---|
| Price | $4.01 | $32.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $5.43 | ★ $52.22 |
| AVG Volume (30 Days) | ★ 3.4M | 668.9K |
| Earning Date | 02-24-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $588,561,000.00 | $518,304,999.00 |
| Revenue This Year | $25.90 | $16.94 |
| Revenue Next Year | $17.88 | $12.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.11 | 15.80 |
| 52 Week Low | $3.48 | $28.29 |
| 52 Week High | $7.04 | $43.18 |
| Indicator | MQ | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 35.31 |
| Support Level | $3.99 | $30.47 |
| Resistance Level | $4.46 | $38.07 |
| Average True Range (ATR) | 0.15 | 1.63 |
| MACD | 0.01 | -0.55 |
| Stochastic Oscillator | 20.95 | 26.79 |
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.